Business Description
Bionet Corp
ISIN : TW0001784007
Total Employee Number:
198Description
Bionet Corp provides blood bank and stem cell services. It is a preservation center for stem cells such as Umbilical Cord Mesenchymal Stem Cells and Dental Pulp Stem Cell Stem.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 10.33 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | 1.44 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.2 | |||||
Beneish M-Score | -2.73 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.6 | |||||
3-Year EBITDA Growth Rate | -8.7 | |||||
3-Year EPS without NRI Growth Rate | 11.4 | |||||
3-Year FCF Growth Rate | -35.5 | |||||
3-Year Book Growth Rate | 6.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 65.78 | |||||
9-Day RSI | 58.76 | |||||
14-Day RSI | 53.2 | |||||
3-1 Month Momentum % | -14.39 | |||||
6-1 Month Momentum % | -41.09 | |||||
12-1 Month Momentum % | -23.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.27 | |||||
Quick Ratio | 4.02 | |||||
Cash Ratio | 3.25 | |||||
Days Inventory | 71.66 | |||||
Days Sales Outstanding | 74.33 | |||||
Days Payable | 42.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.32 | |||||
Dividend Payout Ratio | 1.19 | |||||
3-Year Dividend Growth Rate | 48 | |||||
Forward Dividend Yield % | 1.44 | |||||
5-Year Yield-on-Cost % | 27.74 | |||||
3-Year Average Share Buyback Ratio | 1.3 | |||||
Shareholder Yield % | 3.19 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 55.8 | |||||
Operating Margin % | -0.88 | |||||
Net Margin % | 4.42 | |||||
EBITDA Margin % | 7.6 | |||||
FCF Margin % | 4.97 | |||||
OCF Margin % | 13.07 | |||||
ROE % | 4.57 | |||||
ROA % | 1.85 | |||||
ROIC % | -0.33 | |||||
3-Year ROIIC % | -19.99 | |||||
ROC (Joel Greenblatt) % | 3.27 | |||||
ROCE % | 0.9 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 54.95 | |||||
Forward PE Ratio | 35.49 | |||||
PE Ratio without NRI | 52.06 | |||||
Shiller PE Ratio | 83.56 | |||||
Price-to-Owner-Earnings | 20.46 | |||||
PEG Ratio | 3.01 | |||||
PS Ratio | 2.42 | |||||
PB Ratio | 2.52 | |||||
Price-to-Tangible-Book | 2.58 | |||||
Price-to-Free-Cash-Flow | 49.72 | |||||
Price-to-Operating-Cash-Flow | 18.74 | |||||
EV-to-EBIT | 120.42 | |||||
EV-to-EBITDA | 29.28 | |||||
EV-to-Revenue | 2.22 | |||||
EV-to-FCF | 43.93 | |||||
Price-to-GF-Value | 0.76 | |||||
Price-to-Projected-FCF | 1.77 | |||||
Price-to-DCF (Earnings Based) | 1.67 | |||||
Price-to-DCF (FCF Based) | 4.31 | |||||
Price-to-Median-PS-Value | 1.01 | |||||
Price-to-Peter-Lynch-Fair-Value | 8.44 | |||||
Price-to-Graham-Number | 2.44 | |||||
| Price-to-Net-Current-Asset-Value | 45.33 | |||||
Earnings Yield (Greenblatt) % | 0.83 | |||||
FCF Yield % | 2 | |||||
Forward Rate of Return (Yacktman) % | 8.24 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bionet Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,294.448 | ||
| EPS (TTM) (NT$) | 1.13 | ||
| Beta | -0.0571 | ||
| 3-Year Sharpe Ratio | 0.1 | ||
| 3-Year Sortino Ratio | 0.2 | ||
| Volatility % | 48.93 | ||
| 14-Day RSI | 53.2 | ||
| 14-Day ATR (NT$) | 1.642431 | ||
| 20-Day SMA (NT$) | 59.97 | ||
| 12-1 Month Momentum % | -23.72 | ||
| 52-Week Range (NT$) | 54 - 118 | ||
| Shares Outstanding (Mil) | 51.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bionet Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bionet Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.880964 Cash Dividend | 2026-10-01 | In 36 days | ||
| TWD 1.416294 Cash Dividend | 2025-10-03 | 82.70 (+5.35%) | ||
| TWD 0.709238 Cash Dividend | 2024-09-19 | 108.78 (+9.39%) | ||
| 1.07092:1 Stock Split | 2024-09-19 | 108.78 (+9.39%) | ||
| 1.02089:1 Stock Split | 2010-09-23 | 49.29 (-0.36%) | ||
| 1.03151:1 Stock Split | 2009-08-25 | 61.44 (+1.41%) | ||
| 1.00989:1 Stock Split | 2008-08-25 | 52.38 (-2.82%) |
Show
Entries
Bionet Corp Frequently Asked Questions
What is Bionet Corp(ROCO:1784)'s stock price today?
The current price of ROCO:1784 is NT$62.10. The 52 week high of ROCO:1784 is NT$118.00 and 52 week low is NT$54.00.
When is next earnings date of Bionet Corp(ROCO:1784)?
The next earnings date of Bionet Corp(ROCO:1784) is .
Does Bionet Corp(ROCO:1784) pay dividends? If so, how much?
The Dividend Yield %  of Bionet Corp(ROCO:1784) is 2.32% (As of Today), Highest Dividend Payout Ratio of Bionet Corp(ROCO:1784) was 1.85. The lowest was 0.33. And the median was 0.44. The  Forward Dividend Yield % of Bionet Corp(ROCO:1784) is 1.44%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Bionet Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers